Reply to the letter to the editor 'Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy' by Tannock et al

C Parker; S Gillessen; A Heidenreich; A Horwich

doi:10.1093/annonc/mdw023

Reply to the letter to the editor 'Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy' by Tannock et al

C Parker, S Gillessen, A Heidenreich, A Horwich

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	750-1
Number of pages	2
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	27
Issue number	4
DOIs	https://doi.org/10.1093/annonc/mdw023
Publication status	Published - Apr 2016

Keywords

Humans
Male
Prostate/pathology
Prostatic Neoplasms/diagnosis

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdw023

Cite this

@article{c053a5eaa7c1473c96fae0ec01f485a5,

title = "Reply to the letter to the editor 'Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy' by Tannock et al",

keywords = "Humans, Male, Prostate/pathology, Prostatic Neoplasms/diagnosis",

author = "C Parker and S Gillessen and A Heidenreich and A Horwich",

year = "2016",

month = apr,

doi = "10.1093/annonc/mdw023",

language = "English",

volume = "27",

pages = "750--1",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Elsevier BV",

number = "4",

}

Reply to the letter to the editor 'Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy' by Tannock et al. / Parker, C; Gillessen, S; Heidenreich, A et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 27, No. 4, 04.2016, p. 750-1.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Reply to the letter to the editor 'Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy' by Tannock et al

AU - Parker, C

AU - Gillessen, S

AU - Heidenreich, A

AU - Horwich, A

PY - 2016/4

Y1 - 2016/4

KW - Humans

KW - Male

KW - Prostate/pathology

KW - Prostatic Neoplasms/diagnosis

U2 - 10.1093/annonc/mdw023

DO - 10.1093/annonc/mdw023

M3 - Article

C2 - 26802159

SN - 0923-7534

VL - 27

SP - 750

EP - 751

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

IS - 4

ER -